Clinical Trial Update: Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating HS235 in obese patients with pulmonary hypertension and heart failure with preserved ejection fraction (HFpEF) is listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Drugs mentioned

• HS235

Snippet

Sponsor: 35Pharma Inc | Conditions: Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction | Phase 1 | Status: NOT_YET_RECRUITING